Literature DB >> 29076785

Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.

I Jonathan Pomeraniec1, Hideyuki Kano2, Zhiyuan Xu1, Brandon Nguyen3, Zaid A Siddiqui3, Danilo Silva4, Mayur Sharma4, Hesham Radwan4, Jonathan A Cohen2, Robert F Dallapiazza1, Christian Iorio-Morin5, Amparo Wolf6, John A Jane1, Inga S Grills3, David Mathieu5, Douglas Kondziolka6, Cheng-Chia Lee7, Chih-Chun Wu7, Christopher P Cifarelli8, Tomas Chytka9, Gene H Barnett4, L Dade Lunsford2, Jason P Sheehan1.   

Abstract

OBJECTIVE Gamma Knife radiosurgery (GKRS) is frequently used to treat residual or recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether GKRS should be used early after surgery or if radiosurgery should be withheld until there is evidence of imaging-defined progression of tumor. Given the high incidence of adenoma progression after subtotal resection over time, the present study intended to evaluate the effect of timing of radiosurgery on outcome. METHODS This is a multicenter retrospective review of patients with nonfunctioning pituitary macroadenomas who underwent transsphenoidal surgery followed by GKRS from 1987 to 2015 at 9 institutions affiliated with the International Gamma Knife Research Foundation. Patients were matched by adenoma and radiosurgical parameters and stratified based on the interval between last resection and radiosurgery. Operative results, imaging data, and clinical outcomes were compared across groups following early (≤ 6 months after resection) or late (> 6 months after resection) radiosurgery. RESULTS After matching, 222 patients met the authors' study criteria (from an initial collection of 496 patients) and were grouped based on early (n = 111) or late (n = 111) GKRS following transsphenoidal surgery. There was a greater risk of tumor progression after GKRS (p = 0.013) and residual tumor (p = 0.038) in the late radiosurgical group over a median imaging follow-up period of 68.5 months. No significant difference in the occurrence of post-GKRS endocrinopathy was observed (p = 0.68). Thirty percent of patients without endocrinopathy in the early cohort developed new endocrinopathies during the follow-up period versus 27% in the late cohort (p = 0.84). Fourteen percent of the patients in the early group and 25% of the patients in the late group experienced the resolution of endocrine dysfunction after original presentation (p = 0.32). CONCLUSIONS In this study, early GKRS was associated with a lower risk of radiological progression of subtotally resected nonfunctioning pituitary macroadenomas compared with expectant management followed by late radiosurgery. Delaying radiosurgery may increase patient risk for long-term adenoma progression. The timing of radiosurgery does not appear to significantly affect the rate of delayed endocrinopathy.

Entities:  

Keywords:  ACTH = adrenocorticotrophic hormone; AP = anteroposterior; CC = craniocaudal; GKRS = Gamma Knife radiosurgery; Gamma Knife; NFPA = nonfunctioning pituitary adenoma; SRS = stereotactic radiosurgery; TR = transverse; macroadenoma; nonfunctioning pituitary adenoma; pituitary surgery; stereotactic radiosurgery; transsphenoidal surgery

Mesh:

Year:  2017        PMID: 29076785      PMCID: PMC5924422          DOI: 10.3171/2017.5.JNS163069

Source DB:  PubMed          Journal:  J Neurosurg        ISSN: 0022-3085            Impact factor:   5.115


  64 in total

1.  A single centre's experience of stereotactic radiosurgery and radiotherapy for non-functioning pituitary adenomas with the Linear Accelerator (Linac).

Authors:  P J Wilson; K J De-Loyde; J R Williams; R I Smee
Journal:  J Clin Neurosci       Date:  2012-01-25       Impact factor: 1.961

2.  Pituitary apoplexy treated by transsphenoidal surgery. A clinicopathological and immunocytochemical study.

Authors:  M J Ebersold; E R Laws; B W Scheithauer; R V Randall
Journal:  J Neurosurg       Date:  1983-03       Impact factor: 5.115

3.  Image-guided stereotactic radiosurgery with the CyberKnife for pituitary adenomas.

Authors:  K Kajiwara; K Saito; K Yoshikawa; S Kato; T Akimura; S Nomura; H Ishihara; M Suzuki
Journal:  Minim Invasive Neurosurg       Date:  2005-04

4.  Long-term outcomes after gamma knife stereotactic radiosurgery for nonfunctional pituitary adenomas.

Authors:  Kyung-Jae Park; Hideyuki Kano; Phillip V Parry; Ajay Niranjan; John C Flickinger; L Dade Lunsford; Douglas Kondziolka
Journal:  Neurosurgery       Date:  2011-12       Impact factor: 4.654

Review 5.  Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis.

Authors:  M Mercè Fernández-Balsells; Mohammad Hassan Murad; Amelia Barwise; Juan F Gallegos-Orozco; Anu Paul; Melanie A Lane; Julianna F Lampropulos; Inés Natividad; Lilisbeth Perestelo-Pérez; Paula G Ponce de León-Lovatón; Patricia J Erwin; Jantey Carey; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2011-04       Impact factor: 5.958

6.  Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study.

Authors:  Roberto Attanasio; Paolo Epaminonda; Enrico Motti; Enrico Giugni; Laura Ventrella; Renato Cozzi; Mario Farabola; Paola Loli; Paolo Beck-Peccoz; Maura Arosio
Journal:  J Clin Endocrinol Metab       Date:  2003-07       Impact factor: 5.958

7.  Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth.

Authors:  Y Greenman; G Ouaknine; I Veshchev; I I Reider-Groswasser; Y Segev; N Stern
Journal:  Clin Endocrinol (Oxf)       Date:  2003-06       Impact factor: 3.478

8.  Low-dose Gamma Knife surgery for nonfunctioning pituitary adenomas.

Authors:  Amr M N El-Shehaby; Wael A Reda; Sameh R Tawadros; Khaled M Abdel Karim
Journal:  J Neurosurg       Date:  2012-12       Impact factor: 5.115

9.  Long-term results of stereotactic gamma knife radiosurgery for pituitary adenomas. Specific strategies for different types of adenoma.

Authors:  Tatsuya Kobayashi
Journal:  Prog Neurol Surg       Date:  2009

10.  Gamma knife surgery for treatment of residual nonfunctioning pituitary adenomas after surgical debulking.

Authors:  Marco Losa; Micol Valle; Pietro Mortini; Alberto Franzin; Camillo Ferrari da Passano; Marco Cenzato; Stefania Bianchi; Piero Picozzi; Massimo Giovanelli
Journal:  J Neurosurg       Date:  2004-03       Impact factor: 5.115

View more
  10 in total

Review 1.  Recurrent non-functioning pituitary adenomas: a review on the new pathological classification, management guidelines and treatment options.

Authors:  P D Delgado-López; J Pi-Barrio; M T Dueñas-Polo; M Pascual-Llorente; M C Gordón-Bolaños
Journal:  Clin Transl Oncol       Date:  2018-04-05       Impact factor: 3.405

2.  Outcome of partially irradiated recurrent nonfunctioning pituitary macroadenoma by gamma knife radiosurgery.

Authors:  Chiung-Chyi Shen; Weir-Chiang You; Ming-Hsi Sun; Shinh-Dung Lee; Hsi-Kai Tsou; Yen-Ju Chen; Meei-Ling Sheu; Jason Sheehan; Hung-Chuan Pan
Journal:  J Neurooncol       Date:  2018-06-13       Impact factor: 4.130

3.  Initial Gamma Knife radiosurgery for nonfunctioning pituitary adenomas: results from a 26-year experience.

Authors:  Jinxiu Yu; Yanli Li; Tingting Quan; Xi Li; Chao Peng; Jiamin Zeng; Shunyao Liang; Minyi Huang; Yong He; Yinhui Deng
Journal:  Endocrine       Date:  2020-03-11       Impact factor: 3.633

4.  Growth of Pituitary Macroadenomas Postpartial Resection: Implications for Adjuvant Radiotherapy.

Authors:  Valerie Panet-Raymond; Kushraw Sabit; George Shenouda; Denis Sirhan; Anthony Zeitouni; Luis Souhami
Journal:  J Neurol Surg B Skull Base       Date:  2018-10-10

Review 5.  STEREOTACTIC RADIATION THERAPY IN PITUITARY ADENOMAS, IS IT BETTER THAN CONVENTIONAL RADIATION THERAPY?

Authors:  M L Gheorghiu; M Fleseriu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

6.  Long-term results of Gamma Knife Radiosurgery for Postsurgical residual or recurrent nonfunctioning Pituitary Adenomas.

Authors:  Yinhui Deng; Yanli Li; Xi Li; Lisha Wu; Tingting Quan; Chao Peng; Junyi Fu; Xin Yang; Jinxiu Yu
Journal:  Int J Med Sci       Date:  2020-06-18       Impact factor: 3.738

7.  Management after initial surgery of nonfunctioning pituitary adenoma: surveillance, radiotherapy or surgery?

Authors:  Thomas Charleux; Véronique Vendrely; Aymeri Huchet; Renaud Trouette; Amandine Ferrière; Antoine Tabarin; Vincent Jecko; Hugues Loiseau; Charles Dupin
Journal:  Radiat Oncol       Date:  2022-10-13       Impact factor: 4.309

8.  Post-operative volumes following endoscopic surgery for non-functioning pituitary macroadenomas are predictive of further intervention, but not endocrine outcomes.

Authors:  K Seejore; S A Alavi; S M Pearson; J M W Robins; B Alromhain; A Sheikh; P Nix; T Wilson; S M Orme; A Tyagi; N Phillips; R D Murray
Journal:  BMC Endocr Disord       Date:  2021-06-10       Impact factor: 2.763

9.  Deferred Radiotherapy After Debulking of Non-functioning Pituitary Macroadenomas: Clinical Outcomes.

Authors:  Sarah E Nicholas; Roberto Salvatori; Alfredo Quinones-Hinojosa; Kristin Redmond; Gary Gallia; Michael Lim; Daniele Rigamonti; Henry Brem; Lawrence Kleinberg
Journal:  Front Oncol       Date:  2019-01-10       Impact factor: 6.244

10.  Stereotactic radiosurgery for non-functioning pituitary adenomas: meta-analysis and International Stereotactic Radiosurgery Society practice opinion.

Authors:  Rupesh Kotecha; Arjun Sahgal; Muni Rubens; Antonio De Salles; Laura Fariselli; Bruce E Pollock; Marc Levivier; Lijun Ma; Ian Paddick; Jean Regis; Jason Sheehan; Shoji Yomo; John H Suh
Journal:  Neuro Oncol       Date:  2020-03-05       Impact factor: 12.300

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.